2009-12-23
Prolonged introductory price period
We have had fantastic customer response to the introduction of Osstell ISQ this year. Our sales expectations have been widely exceeded. 

Osstell ISQ is a medical device which, due to the regulatory process, is being successively introduced in all countries around the world. This process will continue in some markets also during the early part of next year. Osstell ISQ will not be introduced in these markets until registration is ready. 

We have therefore decided to prolong the introductory price period and are happy to inform you that the introductory price will be valid for another 6 months. 

The introductory price of 2 499 EUR will be valid until June 30th 2010. 

From July 1st 2010 the ordinary price of 2 950 Euro will apply.

2009-08-18
New Global Business Development Manager and Global Sales Director appointed at Osstell
To manage our strong sales expansion and secure our long term success we have made an organizational change at Osstell. Two appointments at Osstell have been made that are effective from today. We are convinced that these changes will have a positive impact for us all. 

Ola Olsson will take up the new position as Global Business Development Manager. In his new role, Ola will work closely to the local markets, with leading clinician and Osstell users, in our ambition to make Osstell and ISQ a global standard for measuring implant stability. Ola will also continue in his role as Executive Vice President.

Alex Tasevski has accepted the position as Global Sales Director. In this role, Alex is responsible for sales on all existing markets and for all distribution partner relationships. He is also responsible for expanding our business into new markets.

pdf-version

2009-06-29
ISQ 65 or higher is recommended for early loaded implants in a new study
Osstell is used to determine the level of implant stability in a new study by Dr Bornstein. Prior to loading an implant, the authors recommend that a stability level of ISQ 65 is reached, as a minimum. 

A study by Dr Bornstein et. al. investigates the success rate for implants with different surfaces. Osstell is used in the study to determine the level of implant stability using Resonance Frequency Analysis (RFA). According to Dr Bornstein, Osstell is a valuable tool for determining the level of implant stability in early loaded implants. Repeated measurements allow the clinician to compare the ISQ values and monitor the development of the stability. For early loaded implants ISQ 65 or higher should be reached before the implant is loaded. If the implant has a lower ISQ value Dr Bornstein recommends further healing time to increase the stability. Furthermore ISQ is easily understood by patients and makes communication with them easier.

A quote from the study:
"These studies support the ISQ/RFA methods to be a useful tool for the clinician in daily practice, if the concept for early loading is applied. For early loading, a consecutive measurement of ISQ values seems important to compare the values at implant placement and at the day of anticipated loading. If the ISQ value on the day of loading is <65, an additional healing period is recommended, and the ISQ value is measured again 3 weeks later until the required level is reached. This approach is practical and well understood by patients"

The title of the study is: Early Loading of Nonsubmerged Titanium Implants with a Chemically Modified Sand-Blasted and Acid-Etched Surface: 6-Month Results of a Prospective Case Series Study in the Posterior Mandible Focusing on Peri-Implant Crestal Bone Changes and Implant Stability Quotient (ISQ) Values. The study will be published in Clinical Implant Dentistry and Related Research during 2009. If you would like more information or to read the study in its whole you are welcome to contact Osstell at info@osstell.com.

pdf-version

2009-03-03
Shelf-life of SmartPegs has been prolonged from three to five years.
The integrity of the SmartPeg blister package has been evaluated to be maintained at least for five years. This means that SmartPegs with expity date before December 13, 2011, remain sterile and unaffected two years after the printed expiry date.

Example: unopened SmartPegs with marked expiry date 05/2010 will have new expiry date 05/2012.

SmartPegs with expiry date after December 13, 2011, are marked according to the five years shelf-life.

2009-02-23
Say hello to the new Osstell ISQ!
Osstell ISQ – a new implant stability meter from Osstell, was launched in the U.S. during the AO meeting in San Diego. It is faster, more stylish and easier to use than ever before.

The meter comes in a new design with an attractive, backlit display, a solid base on which it stands firmly and the probe is made of metal, to facilitate sterilization. The probe is attached to a cable connected to the instrument, and the docking station, which previously was separate, is now built in. The Firmware has been upgraded with the focus on maximum user-friendliness and efficiency. With Osstell ISQ you can now get your measurements faster and more easily than ever before.

Osstell ISQ is available for sale in the U.S. and Europe and will be launched in other markets shortly. In order to buy an Osstell ISQ or get more information about when the instrument will be available in your market, please contact your local distributor or Osstell at info@osstell.com.

pdf-version

Read more about Osstell ISQ

2008-10-27
Osstell is proud to present Citagenix as its new distributor in Canada
Citagenix has become the largest source of knowledge and experience in bone regeneration in the Canadian medical device industry. They have a strong track record of commercializing their products through direct sales and distribution channels in Canada as well as marketing their products internationally with selected partners. 

“We look forward to our cooperation with Citagenix and are convinced they will be a strong partner and successful in selling and promoting Osstell Mentor in Canada” said Ola Olsson, Global Marketing and Sales Manager at Osstell AB.

2008-10-01
Osstell strengthens organization with recruitment of Mr. Alex Tasevski, Export Markets Director
We are happy to welcome Mr. Alex Tasevski to our team. Alex has previously held key positions in exports at Nobel Biocare and more recently the position of export manager at Ospol, a company that was previously a part of the Biolin Group. Alex has a proven track record of successful export market development from his previous positions and we look forward to having him on our team. He will take on the challenge of expanding Osstell’s business in Central & Eastern Europe, the Middle East, and Africa.

2008-09-17
Osstell recruits marketing coordinator
We welcome Ms. Ida Andersson as marketing coordinator at Osstell. She joins us from a marketing position at a medtech company where she managed marketing activities. Ida will help promote and market Osstell.  

2008-07-01
New study gives further support to RFA as a superior method for determining implant stability
A study by Zix J et. al (Int J Oral Maxillofac Implants. 2008 May-Jun;23(3):525-30.) compares different techniques for measuring stability in dental implants. The stability on 213 implants in 65 patients were measured using different techniques and the authors conclude that RFA (Resonance Frequency Analysis) is the most precise. RFA is the technique used in all Osstell instruments.